 | • レポートコード：MRC2312MG11462 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、71ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥455,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥682,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模と予測を収録しています。・世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「生ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル主要企業は、CAVAC、 Green Cross Veterinary Products、 Harrisvaccines、 Komipharm、 Nisseiken、 Qilu Animal Health、 Zoetis、 Wuhan Keqian、 China Animal Husbandry Industry、 Luoyang Huizhong、 Shanghai Hile Bio-Technology、 Harbin Weike、 Harbin Pharmaceutical Group、 Jiangsu Nannongなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：タイプ別市場シェア、2022年 ・生ワクチン、不活化ワクチン 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：用途別、2018年-2023年、2024年-2029年 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：用途別市場シェア、2022年 ・子豚、成豚 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル売上、2018年-2023年 ・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル売上シェア、2022年 ・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル販売量、2018年-2023年 ・主要企業における豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CAVAC、 Green Cross Veterinary Products、 Harrisvaccines、 Komipharm、 Nisseiken、 Qilu Animal Health、 Zoetis、 Wuhan Keqian、 China Animal Husbandry Industry、 Luoyang Huizhong、 Shanghai Hile Bio-Technology、 Harbin Weike、 Harbin Pharmaceutical Group、 Jiangsu Nannong ************************************************************* ・調査・分析レポートの概要 豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場の定義 市場セグメント 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模：2022年 VS 2029年 世界の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの豚伝染性胃腸炎＆流行性下痢用デュアルワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の豚伝染性胃腸炎＆流行性下痢用デュアルワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：生ワクチン、不活化ワクチン 豚伝染性胃腸炎＆流行性下痢用デュアルワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：子豚、成豚 豚伝染性胃腸炎＆流行性下痢用デュアルワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別豚伝染性胃腸炎＆流行性下痢用デュアルワクチン市場規模 2022年と2029年 地域別豚伝染性胃腸炎＆流行性下痢用デュアルワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CAVAC、 Green Cross Veterinary Products、 Harrisvaccines、 Komipharm、 Nisseiken、 Qilu Animal Health、 Zoetis、 Wuhan Keqian、 China Animal Husbandry Industry、 Luoyang Huizhong、 Shanghai Hile Bio-Technology、 Harbin Weike、 Harbin Pharmaceutical Group、 Jiangsu Nannong ... |
This research report provides a comprehensive analysis of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market presents opportunities for various stakeholders, including Piglet, Adult Pig. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market.
Market Overview: The report provides a comprehensive overview of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Live Vaccine, Inactivated Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Live Vaccine
Inactivated Vaccine
Market segment by Application
Piglet
Adult Pig
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CAVAC
Green Cross Veterinary Products
Harrisvaccines
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Wuhan Keqian
China Animal Husbandry Industry
Luoyang Huizhong
Shanghai Hile Bio-Technology
Harbin Weike
Harbin Pharmaceutical Group
Jiangsu Nannong
Outline of Major Chapters:
Chapter 1: Introduces the definition of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine, market overview.
Chapter 2: Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Overall Market Size
2.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size: 2022 VS 2029
2.2 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players in Global Market
3.2 Top Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies Ranked by Revenue
3.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue by Companies
3.4 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales by Companies
3.5 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Vaccine
4.1.3 Inactivated Vaccine
4.2 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue & Forecasts
4.2.1 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales & Forecasts
4.3.1 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2023
4.3.2 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2024-2029
4.3.3 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2022 & 2029
5.1.2 Piglet
5.1.3 Adult Pig
5.2 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue & Forecasts
5.2.1 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales & Forecasts
5.3.1 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2023
5.3.2 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2024-2029
5.3.3 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue & Forecasts
6.2.1 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales & Forecasts
6.3.1 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2023
6.3.2 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2024-2029
6.3.3 By Region – Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.4.3 US Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.4.4 Canada Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.4.5 Mexico Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.5.3 Germany Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.4 France Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.5 U.K. Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.6 Italy Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.7 Russia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.5.9 Benelux Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.6.3 China Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.4 Japan Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.5 South Korea Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.6.7 India Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.7.3 Brazil Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.7.4 Argentina Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales, 2018-2029
6.8.3 Turkey Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8.4 Israel Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
6.8.6 UAE Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CAVAC
7.1.1 CAVAC Company Summary
7.1.2 CAVAC Business Overview
7.1.3 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.1.4 CAVAC Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CAVAC Key News & Latest Developments
7.2 Green Cross Veterinary Products
7.2.1 Green Cross Veterinary Products Company Summary
7.2.2 Green Cross Veterinary Products Business Overview
7.2.3 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.2.4 Green Cross Veterinary Products Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Green Cross Veterinary Products Key News & Latest Developments
7.3 Harrisvaccines
7.3.1 Harrisvaccines Company Summary
7.3.2 Harrisvaccines Business Overview
7.3.3 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.3.4 Harrisvaccines Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Harrisvaccines Key News & Latest Developments
7.4 Komipharm
7.4.1 Komipharm Company Summary
7.4.2 Komipharm Business Overview
7.4.3 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.4.4 Komipharm Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Komipharm Key News & Latest Developments
7.5 Nisseiken
7.5.1 Nisseiken Company Summary
7.5.2 Nisseiken Business Overview
7.5.3 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.5.4 Nisseiken Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Nisseiken Key News & Latest Developments
7.6 Qilu Animal Health
7.6.1 Qilu Animal Health Company Summary
7.6.2 Qilu Animal Health Business Overview
7.6.3 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.6.4 Qilu Animal Health Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Qilu Animal Health Key News & Latest Developments
7.7 Zoetis
7.7.1 Zoetis Company Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.7.4 Zoetis Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Zoetis Key News & Latest Developments
7.8 Wuhan Keqian
7.8.1 Wuhan Keqian Company Summary
7.8.2 Wuhan Keqian Business Overview
7.8.3 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.8.4 Wuhan Keqian Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Wuhan Keqian Key News & Latest Developments
7.9 China Animal Husbandry Industry
7.9.1 China Animal Husbandry Industry Company Summary
7.9.2 China Animal Husbandry Industry Business Overview
7.9.3 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.9.4 China Animal Husbandry Industry Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 China Animal Husbandry Industry Key News & Latest Developments
7.10 Luoyang Huizhong
7.10.1 Luoyang Huizhong Company Summary
7.10.2 Luoyang Huizhong Business Overview
7.10.3 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.10.4 Luoyang Huizhong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Luoyang Huizhong Key News & Latest Developments
7.11 Shanghai Hile Bio-Technology
7.11.1 Shanghai Hile Bio-Technology Company Summary
7.11.2 Shanghai Hile Bio-Technology Business Overview
7.11.3 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.11.4 Shanghai Hile Bio-Technology Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Shanghai Hile Bio-Technology Key News & Latest Developments
7.12 Harbin Weike
7.12.1 Harbin Weike Company Summary
7.12.2 Harbin Weike Business Overview
7.12.3 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.12.4 Harbin Weike Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Harbin Weike Key News & Latest Developments
7.13 Harbin Pharmaceutical Group
7.13.1 Harbin Pharmaceutical Group Company Summary
7.13.2 Harbin Pharmaceutical Group Business Overview
7.13.3 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.13.4 Harbin Pharmaceutical Group Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.14 Jiangsu Nannong
7.14.1 Jiangsu Nannong Company Summary
7.14.2 Jiangsu Nannong Business Overview
7.14.3 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Major Product Offerings
7.14.4 Jiangsu Nannong Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Jiangsu Nannong Key News & Latest Developments
8 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity, Analysis
8.1 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity, 2018-2029
8.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Supply Chain Analysis
10.1 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Industry Value Chain
10.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Upstream Market
10.3 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer